is there still a shortage of semaglutide Makers compounded Wegovy, Ozempic threatened by FDA move FDA crackdown on off-brand Ozempic
Description
The medications now available - GLP-1 receptor agonists like semaglutide and tirzepatide - are a real tool for the right patient

The market is expanding because GLP-1 prescriptions moved beyond a narrow diabetes base and became more common in weight management by late 2025, which widened the pool of users who need help with protein intake, muscle retention, and micronutrient balance

If this patient continues a 10 mg dose but switches to q2wk, then they reduce cost by 50% and maintain 75% of their weight loss

Insights into the underlying pathogenesis and therapeutic potential of endoplasmic reticulum stress in degenerative musculoskeletal diseases
As GLP-1RAs continue to grow in popularity for managing type 2 diabetes and obesity, this pharmacovigilance study calls for increased awareness and careful perioperative planning among clinicians
Their canonical activity is the degradation of ECM proteins, even if they exhibit pleiotropic functions, modulating a diverse array of biological processes, such as cell migration, leukocyte activation and inflammatory responses [89, 92]
